Back from Extinction: How Colossal Is Charting a New Frontier in Genomics

[ResidentialBusiness]

Featuring Ben Lamm, Founder and CEO, Colossal Biosciences and Joe Manganiello, Actor, Producer. Moderated by Kc Ifeanyi, Executive Director of Editorial Programming, Fast Company

Since Colossal Biosciences launched in 2021, it’s skyrocketed to a $10.2 billion valuation to fund its mission of de-extinction. For Colossal, it’s more than the buzzy headlines that its resurrecting the woolly mammoth or the dodo—the company’s aim is to combat biodiversity loss and regenerate ecosystems and climates that have degraded over time. Hear from Colossal CEO Ben Lamm on how he’s making science fiction a reality—and how it could benefit us all.

View the full article